(Q38788207)

6 September 2017

Pathology of Endometrial Carcinoma (English)

1 reference

6 September 2017

Sigurd F Lax

1

1 reference

PubMed ID

27910065

6 September 2017

language of work or name

English

0 references

publication date

1 January 2017

1 reference

Advances in Experimental Medicine and Biology

6 September 2017

1 reference

6 September 2017

943

1 reference

6 September 2017

75-96

1 reference

6 September 2017

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

The epidemiology of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Physical activity and endometrial cancer risk, a systematic review of current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Peripheral aromatization as a risk factor for breast and endometrial cancer in postmenopausal women: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Case-control study of endogenous steroid hormones and endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Two pathogenetic types of endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Theories of endometrial carcinogenesis: a multidisciplinary approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Endometrial carcinoma: molecular alterations involved in tumor development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Molecular pathology of endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Relationship between PTEN, DNA mismatch repair, and tumor histotype in endometrial carcinoma: retained positive expression of PTEN preferentially identifies sporadic non-endometrioid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Molecular alterations of PIK3CA in uterine carcinosarcoma, clear cell, and serous tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Integrated genomic characterization of endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

A clinically applicable molecular-based classification for endometrial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Molecular characterization of uterine clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Targeted mutation analysis of endometrial clear cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Frequent CCNE1 amplification in endometrial intraepithelial carcinoma and uterine serous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Lifetime cancer risks in individuals with germline PTEN mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Endometrial adenocarcinoma in Norway. A study of a total population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Histological features associated with occult lymph node metastasis in FIGO clinical stage I, grade I endometrioid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Endometrioid carcinoma of the endometrium with an invasive component of minimal deviation carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

The significance of squamous differentiation in endometrial carcinoma. Data from a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Endometrial adenocarcinoma with squamdus cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Carcinoma of the endometrium: I. A clinicopathologic study of clear-cell carcinoma and secretory carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Outcomes of patients with uterine serous carcinoma using the revised FIGO staging system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Utility of α-methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Clear cell carcinoma of the endometrium: a histopathological and clinical study of 97 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Clear cell carcinoma of the endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Undifferentiated carcinoma of the endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Evaluation of the relationship between adenosarcoma and carcinosarcoma and a hypothesis of the histogenesis of uterine sarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Carcinosarcoma (malignant mixed müllerian (mesodermal) tumor) of the female genital tract: immunohistochemical and ultrastructural analysis of 28 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Large cell neuroendocrine carcinoma of the endometrium: an extremely uncommon diagnosis, but worth the efforts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

The prognostic value of nuclear grading and the revised FIGO grading of endometrial adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

The reproducibility of a binary tumor grading system for uterine endometrial endometrioid carcinoma, compared with FIGO system and nuclear grading.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

FIGO staging of endometrial adenocarcinoma: a critical review and proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Accuracy of endometrial sampling compared to conventional dilatation and curettage in women with abnormal uterine bleeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Endometrial cancer: accuracy of the finding of a well differentiated tumor at dilatation and curettage compared to the findings at subsequent hysterectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Validation of intraoperative risk assessment on frozen section for surgical management of endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Tailoring lymphadenectomy according to the risk of lymph node metastasis in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Sentinel lymph node in endometrial cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Sentinel lymph node mapping for endometrial cancer: a modern approach to surgical staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive procedures on the detection of stage IIIC endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

How accurate is frozen section histology of pelvic lymph nodes in patients with endometrial cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Abnormalities of E- and P-cadherin and catenin (β-, γ-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Race disparities between black and white women in the incidence, treatment, and prognosis of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Atypical polypoid adenomyoma: a systematic review of the English literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Comparison of estrogen and progesterone receptor, Ki-67, and p53 immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous, mucinous, secretory, and ciliated cell differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Immunohistochemical differences between mucinous and microglandular adenocarcinomas of the endometrium and benign endocervical epithelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

WT1, p53 and hormone receptor expression in uterine serous carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Clear cell carcinoma of the endometrium: an analysis of 21 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Minor serous and clear cell components adversely affect prognosis in ''mixed-type'' endometrial carcinomas: a clinicopathologic study of 36 stage-I cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

An evaluation of prognostic factors in uterine carcinosarcoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Carcinoid tumour of the uterine corpus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Small-cell carcinoma of the endometrium. A clinicopathological study of sixteen cases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Small cell neuroendocrine carcinoma of the endometrium.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. A Gynecologic Oncology Group study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Prognosis and reproducibility of new and existing binary grading systems for endometrial carcinoma compared to FIGO grading in hysterectomy specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Lymphadenectomy increases the prognostic value of the revised 2009 FIGO staging system for endometrial cancer: A multi-center study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Comparison of FIGO 1989 and 2009 recommendations on staging of endometrial carcinoma: pathologic analysis and cervical status in 123 consecutive cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

The grading of lymphovascular space invasion in endometrial carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Peritoneal cytology: A risk factor of recurrence for non-endometrioid endometrial cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

Intraoperative frozen section examination of myometrial invasion depth in patients with endometrial carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43139-0_3

10.1007/978-3-319-43139-0_3

31 March 2020

Identifiers

DOI

0 references

PubMed ID

27910065

1 reference

PubMed ID

27910065